### 17412 Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices

Review Officer, CDC, 1600 Clifton Road NE., Mailstop D–72, Atlanta, Georgia 30333, Telephone: (404) 639–4796.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dana Redford, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention.
[FR Doc. 2013–06438 Filed 3–20–13; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Disease, Disability, and Injury Prevention and Control Special**  **Emphasis Panel (SEP): Initial Review**

The meeting announced below concerns Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa, FOA GH13– 002, initial review.

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 1:00 p.m.–4:30 p.m., May 23, 2013 (Closed).

Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463.

Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa, FOA GH13–002, initial review.’’

Contact Person for More Information: Diana Bartlett, Scientific Review Officer, Office of the Associate Director for Science, Office of Science Quality, CDC, 1600 Clifton Road NE., Mailstop D–72, Atlanta, Georgia 30033, Telephone (404) 639–4938, zxd5@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013–06437 Filed 3–20–13; 8:45 am]

**BILLING CODE 4163–18–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**Disease, Disability, and Injury Prevention and Control Special**  **Emphasis Panel (SEP): Funding Opportunity Announcement, Initial**  **Review**

The meeting announced belowconcerns Indoor Environment of LowIncome Renovated Multifamily Housing in the Western Region of the United States (U01), FOA EH13–001, initial review.
**SUMMARY :**  This document corrects a notice that was published in the Federal Register on February 28, 2013 (78 FR 13677). The meeting announcement and matters to be discussed should read as follows:

The meeting announced belowconcerns Indoor Environment of LowIncome Renovated Multifamily Housing in the Western Region of the United States (U01), FOA EH13–001, initial review.

Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Indoor Environment of Low-Income Renovated Multifamily Housing in the Western Region of the United States (U01), FOA EH13–001’’.

**FOR FURTHER INFORMATION CONTACT :**  J. Felix Rogers, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488–
4334.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2013–06434 Filed 3–20–13; 8:45 am]

**BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Centers for Medicare & Medicaid Services** 

**[Document Identifier CMS–R–218]**

**Agency Information Collection Activities: Submission for OMB**  **Review; Comment Request**

**AGENCY :**  Centers for Medicare & Medicaid Services, HHS.

In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

1. Type of Information Collection Request: Reinstatement of a previously approved collection; Title of Information Collection: Health Insurance Portability and Accountability Act (HIPAA) Standards for Electronic Transactions and Supporting Regulations in 45 CFR Part
162. Use: This information collection request has no substantive changes since the last OMB approval in 2008. The adopted transaction standards currently in use for electronic transactions (Version 4010/4010a) are compatible with the ICD–9–CM adopted code set that is used to report diagnoses and hospital inpatient services. However, the ICD–10 codes cannot be used with Version 4010/4010a, because this version does not have a specific qualifier or indicator for reporting ICD– 10 codes.

Version 5010 supports the use of the ICD–10 code set by making available a qualifier to indicate that an ICD–10 code is being reported. Like ICD–9, ICD–10 codes are reported in claim and payment transactions, as well as eligibility inquiries and responses and requests for referrals and authorizations. In Version 5010, the number of codes required in any given transaction does not change. It is possible that a fewer


### 17413 Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices

number of codes in a given transaction may be necessary to report the same information reported with ICD–9 codes because ICD–10 codes are more specific. Form Number: CMS–R–218 (OCN: 0938–0866). Frequency: Occasionally. Affected Public: Private Sector (Business or other for-profits, Not-for-profit institutions). Number of Respondents: 696,026. Total Annual Responses: 696,026. Total Annual Hours: 6,960,260. (For policy questions regarding this collection contact Gladys Wheeler at 410–786–0273. For all other issues call 410–786–1326.)

To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’ Web site address at http://www.cms.hhs.gov/ PaperworkReductionActof1995, or Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786–
1326.

To be assured consideration, comments and recommendations for the proposed information collections must be received by the OMB desk officer at the address below, no later than 5 p.m.

on April 22, 2013.

OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395–6974, Email: OIRA

_submission@omb.eop.gov.

Dated: March 18, 2013. Martique Jones, Deputy Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2013–06534 Filed 3–20–13; 8:45 am]

**BILLING CODE 4120–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Administration for Children and Families** 

**[CFDA Number: 93.576]**

**Announcement of the Award of an Urgent Single-Source Grant to the**  **Center for Survivors of Torture in Dallas, TX** 

**AGENCY :**  Office of Refugee Resettlement, Administration for Children and Families, Department of Health and Human Services.

**ACTION :**  Announcement of the award of an urgent single-source grant to the Center for Survivors of Torture to provide mental health services for refugees. **SUMMARY :**  The Administration for Children and Families (ACF), Office of Refugee Resettlement (ORR) announces the award of an urgent single-source grant in the amount of $250,000 to the Center for Survivors of Torture (CST) in Dallas, TX to ensure incoming refugee populations in Texas have access to mental health services.

**DATES :**  The project period for the award is February 1, 2013 through January 31,
2014.

**FOR FURTHER INFORMATION CONTACT :**  Kenneth Tota, Deputy Director, Office of Refugee Resettlement, 901 D Street SW., Washington, DC 20047. Telephone: 202–401–4858. Email: kenneth.tota@acf.hhs.gov.

**SUPPLEMENTARY INFORMATION :**  Approximately 45,000 individual refugees reside in the areas covered by the Center for Survivors of Torture. Texas and the surrounding region have a demonstrated history of being a top resettlement location with one of the highest concentrations of refugees in the United States. In the past few years, the Office of Refugee Resettlement (ORR) has seen an increasing need for mental health services associated with the three primary refugee populations from Iraq, Burma and Bhutan who have suffered extreme trauma and torture due to war and genocide in those countries. Refugees from Bhutan have specifically demonstrated a high incidence of suicide upon arrival to the U.S. ORR has been working closely with the Centers for Disease Control (CDC) to assess this situation. The CDC recently published a study recommending enhanced mental health services for incoming refugees from Bhutan.

This fiscal year the program is seeing a significant increase in resettlement of refugees from the Democratic Republic of Congo. The United Nations High Commissioner for Refugees (UNHCR) has determined this group is particularly at risk due to decades of extreme violence in the Democratic Republic of Congo and recent arrivals have shown a compelling need for mental health services upon arrival. Furthermore, CST is the only accredited mental health care provider of specialized refugee mental health treatment services in Texas and the surrounding area.

CST services are critical to meeting refugee mental health needs by providing services such as an initial assessment, counseling to: children, adolescents, adults, couples, and families. Additionally, CST provides group therapy, psychoeducational groups, testing for mental health conditions, and medication management. In addition to these direct services, CST also provides training to other agencies in the area to include schools, health clinics, and social services agencies on refugee mental health issues.

Due to the high number of refugees being resettled in this region, with no other demonstrated provider of expert mental health services to this population, this grant is urgent and critical to those in need of such services. According to the Department of State, Texas is projected to receive the highest number of refugees admitted to the U.S. in FY13. Through this grant ORR will ensure there is no disruption in much needed mental health services to these particularly at risk populations. This urgent grant will support the provision of these much needed mental health services to ensure these refugees areafforded a successful path to selfsufficiency.

Statutory Authority: Section 412 (c)(1)(A)(iii) of the Immigration and Nationality Act, as amended and the Refugee Assistance Extension Act of 1986, Pub. L. 99– 605 (8 U.S.C. 1101).
Eskinder Negash, Director, Office of Refugee Resettlement.
[FR Doc. 2013–06517 Filed 3–20–13; 8:45 am]

**BILLING CODE 4184–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Food and Drug Administration**

**[Docket No. FDA–2013–N–0001]**

**Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting** 

**AGENCY :**  Food and Drug Administration, HHS.

**ACTION :**  Notice.

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. This meeting is being rescheduled due to the postponement of the March 7, 2013, Pulmonary-Allergy Drugs Advisory Committee meeting due to unanticipated weather conditions.

Name of Committee: PulmonaryAllergy Drugs Advisory Committee.

General Function of the Committee: To provide advice and recommendations to the Agency on FDA’s regulatory issues.

Date and Time: The meeting will be held on April 17, 2013, from 8 a.m. to 5 p.m. This meeting is being rescheduled because of a postponed meeting announced in the Federal